Due to Brexit, the European Medicines Agency will be forced to leave London in the future
The Danish government has unveiled that it will work towards Copenhagen being chosen as the future headquarters of the European Medicines Agency (EMA), when it eventually relocates from London in the wake of Brexit.
The government underlined Denmark’s strong tradition for protecting patient security, its important research environment, and how it has become a force when it comes to having an innovative pharmaceutical industry.
“I’m pleased that we can formally launch Copenhagen’s candidacy as the new headquarters for the EMA – we’ve worked months on it,” said Anders Samuelsen, the foreign minister.
“There is no doubt that the competition is stiff, but I’m convinced that placing the EMA in Copenhagen will be a huge benefit to Denmark, the EMA and the EU.”
The agency and its 900 employees will be forced to leave London and the UK following the Brexit vote last year.